Skip to main content
. 2018 Mar 18;2018:3513206. doi: 10.1155/2018/3513206

Table 4.

Comparison of treatments between A-AIH and C-AIH before liver biopsy.

Acute
n = 32 (40.0%)
Chronic
n = 48 (60.0%)
P
No treatment 1 (3.1%) 6 (12.5%) 0.078
General treatment 21 (65.6%) 31 (64.6%)
General treatment + immunosuppressants 1 (3.1%) 5 (10.4%)
General treatment + UDCA 8 (25%) 3 (6.3%)
General treatment + immunosuppressants + UDCA 1 (3.1%) 3 (6.3%)

Time of treatment (months) 2 (0.50, 12) 1 (0.33, 12) 0.805